(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes

PurposeAdvanced heart failure is associated with poor quality of life and can progress to cardiogenic shock. Continuous inotropes serve stabilize patients while further advanced therapies be considered. For those patient's being bridged LVAD, right ventricular assessment essential as may supply biventricular support without altering interdependence, which compromised post LVAD placement.MethodsWe retrospectively reviewed all undergoing durable implant from 2018-2022. Thirty eight were included in this analysis.ResultsThirty on continuous (CI) 8 not inotropes(NI) implanted during time. Temporary MCS(tMCS) was required 21 CI NI patients. Mean PAPI pre tMCS similar at 2.4 the group 2.3 group, mean 2.9 compared 5.25 group. Post 2.0 for both groups. days inotrope use shorter 11 vs 15 days. Survival discharge 93%, 83% 3-months 66.7% 6-month survival. In 100% survived discharge, 87.5% 3-month, 71.4% Further breakdown by dose (table 1) reveals that high had highest morbidity lowest survival.ConclusionThe common acute decompensated a bridge LVAD. Our experience underscores importance timely mechanical unloading avoidance high-dose vasoactive drugs management these tenuous While augment outcomes, we see dysfunction dynamic better outcomes when addressed early. Advanced placement. We analysis. The